Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/19/1999 | US5861487 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
01/19/1999 | US5861485 Polypeptides involved in body weight disorders, including obesity |
01/19/1999 | US5861484 Treatment of psoriasis, rheumatoid arthritis, hemangiomas, angiofibromas, diabetic retinopathy, neovascular glaucoma,and other vegf-induced pathological angiogenesis and vascular permeability conditions, such as tumor vascularization |
01/19/1999 | US5861482 Genetic mapping |
01/19/1999 | US5861480 Capable of isolation from seeds of aralia or impatiens exhibit antifungal and antibacterial activity |
01/19/1999 | US5861378 Polypeptides having specified amino acid sequences; antiseptics, effective against grampositive and gramnegative bacteria |
01/19/1999 | US5861377 Antistasin type serine protease inhibitors |
01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
01/19/1999 | US5861312 Recognition component; hybridization; dna expression vectors; genetic engineering |
01/19/1999 | US5861310 Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor |
01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
01/19/1999 | US5861308 Isolated nucleic acids associated with T cell activation and uses thereof |
01/19/1999 | US5861307 Liposomes embedded with dna; antitumor agents; apotosis |
01/19/1999 | US5861300 Plant transformation vector which comprises a nucleotide sequence which encodes an amino acid sequence having 2-5a-dependent rnase activity |
01/19/1999 | US5861299 Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals |
01/19/1999 | US5861295 Thermostable enzymes, such as dna polymerases and restriction endonucleases, that are substantially free from contamination with nucleic acids are produced by permeabilizing a thermophilic bacterial cell to form a spheroplast using a |
01/19/1999 | US5861293 Glycosylate indolopyrrolocarbazole derivatives conveniently and economically |
01/19/1999 | US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
01/19/1999 | US5861288 Catalytic DNA |
01/19/1999 | US5861285 Fusion dna sequence, obtained by fusing a gene coding for another useful protein to a fragment of a maga gene coding for a protein bound to an organic membrane for covering magnetic particles produced in cells of a magnetic bacterium amb-1 |
01/19/1999 | US5861284 Method for producing a biologically active recombinant cysteine-free parathyroid hormone (1-34) |
01/19/1999 | US5861283 DNA encoding a limbic system-associated membrane protein |
01/19/1999 | US5861282 Mutant constructs; vaccines; genetic engineering |
01/19/1999 | US5861281 Lacc |
01/19/1999 | US5861280 Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production |
01/19/1999 | US5861279 Using peanut agglutinin as lectin in scintillation proximity assay |
01/19/1999 | US5861277 Exogenous protein expression in plants and cells, vectors, dna fusion and polynucleotides also introns for genomes, seeds and plant food |
01/19/1999 | US5861276 CDNAS encoding murine antibody against human plasma apolipoprotein B-100 |
01/19/1999 | US5861275 Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same |
01/19/1999 | US5861274 Nucleic acids encoding peroxisome proliferator-activated receptor |
01/19/1999 | US5861273 Inserting a copy of a gene encoding the heterologous protein of interest into the chromosome of a host cell |
01/19/1999 | US5861271 Binding domain having amino acid sequence corresponding to that of a cellulase from trichoderma |
01/19/1999 | US5861267 Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity |
01/19/1999 | US5861259 Immunoassays for human cyclin E |
01/19/1999 | US5861258 Use of the alpha interferon receptor and cells which express the receptor, for identification of alpha interferon agonists |
01/19/1999 | US5861252 Method of analysis or assay for polynucleotides and analyzer or instrument for polynucleotides |
01/19/1999 | US5861250 Protecting nucleic acids and methods of analysis |
01/19/1999 | US5861240 Isolated human herpesvirus type 8 sequences and uses thereof |
01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
01/19/1999 | US5861161 Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
01/19/1999 | US5861160 Vaccines for swine; epitope amino acid sequences; genetic engineering |
01/19/1999 | US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response |
01/19/1999 | US5861155 Humanized antibodies and uses thereof |
01/19/1999 | US5861151 Soluble fusion molecules with binding specificity for cell adhesion molecules |
01/19/1999 | US5861150 Recombinant human CSF-1 dimer and compositions thereof |
01/19/1999 | CA2139552C Use of self-incompatibility receptor proteins (slg and srk) of plants for the treatment of allergic diseases |
01/19/1999 | CA2105382C Recombinant hybrid porin epitopes |
01/19/1999 | CA2093152C Integrative gene-expression in food-grade microorganisms |
01/19/1999 | CA2025900C Derivative of tissue-type plasminogen activator |
01/19/1999 | CA2013573C Vaccines containing avirulent phop-type microorganisms |
01/19/1999 | CA2004632C Expression induction method |
01/19/1999 | CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
01/19/1999 | CA1340324C Plants with modified stamen cells |
01/19/1999 | CA1340323C Rna catalyst for cleaving specific rna sequences |
01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
01/18/1999 | CA2237160A1 Gida1 |
01/18/1999 | CA2237147A1 Novel ratb |
01/18/1999 | CA2237143A1 Novel rata |
01/18/1999 | CA2237140A1 Novel tarf |
01/18/1999 | CA2237050A1 Histidine kinase |
01/18/1999 | CA2237043A1 Response regulator |
01/17/1999 | CA2237162A1 Novel glucose kinase |
01/16/1999 | CA2237784A1 Novel compounds |
01/15/1999 | CA2220849A1 A human pelota homolog |
01/14/1999 | WO1999001940A1 Biological data |
01/14/1999 | WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
01/14/1999 | WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
01/14/1999 | WO1999001578A1 Assaying nucleotides in solution using a fluorescent intensity quenching effect |
01/14/1999 | WO1999001574A1 Method for diagnosing alzheimer disease |
01/14/1999 | WO1999001572A2 Methods for rapidly detecting methicillin resistant staphylococci |
01/14/1999 | WO1999001571A2 Compositions and methods for detecting vancomycin resistant enterococci by cycling probe reactions |
01/14/1999 | WO1999001565A1 Method for increasing secretion of proteins in eukaryotic host cells |
01/14/1999 | WO1999001563A1 Plasmids for plant transformation and method for using the same |
01/14/1999 | WO1999001562A1 Protein producing cell containing multiple copies of a desired gene and a screenable marker but no selection marker |
01/14/1999 | WO1999001561A1 IMPROVED PROCESS FOR THE PRODUCTION OF β-LACTAMS |
01/14/1999 | WO1999001560A1 Vertebrate telomerase genes and proteins and uses thereof |
01/14/1999 | WO1999001559A1 Novel mapk kinase |
01/14/1999 | WO1999001558A1 Plant genes and polypeptides and uses thereof |
01/14/1999 | WO1999001557A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
01/14/1999 | WO1999001556A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
01/14/1999 | WO1999001555A1 Genes for niemann-pick type c disease |
01/14/1999 | WO1999001554A1 Mammalian secretory peptide-9 |
01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
01/14/1999 | WO1999001552A1 Fluorescent proteins as cell-type specific reporter |
01/14/1999 | WO1999001551A2 Novel inhibitor of cellular proliferation |
01/14/1999 | WO1999001549A1 Transcriptional activators with graded transactivation potential |
01/14/1999 | WO1999001548A2 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
01/14/1999 | WO1999001547A1 Cloning and characterization of a human adenylyl cyclase |
01/14/1999 | WO1999001546A1 Cloning and characterization of a human adenylyl cyclase |
01/14/1999 | WO1999001545A1 STARCH CONVERSION PROCESS USING THERMOSTABLE ISOAMYLASES FROM $i(SULFOLOBUS) |
01/14/1999 | WO1999001542A1 IKK-β PROTEINS, NUCLEIC ACIDS AND METHODS |
01/14/1999 | WO1999001541A1 IKK-α PROTEINS, NUCLEIC ACIDS AND METHODS |
01/14/1999 | WO1999001539A1 A process for purification of pcr test samples |
01/14/1999 | WO1999001476A1 CRYSTAL STRUCTURES OF ANTI-FACTOR IX Fab FRAGMENTS AND METHODS OF USE FOR PEPTIDOMIMETIC DESIGN |
01/14/1999 | WO1999001475A2 Human antibody against a fusion (poly) peptide or protein presenting a part having at least six histidines |
01/14/1999 | WO1999001474A1 Methods for the isolation of proteinase inhibitor proteins from potato tubers |
01/14/1999 | WO1999001473A2 Anti-bacterial methods and materials |
01/14/1999 | WO1999001471A1 Nik proteins, nucleic acids and methods |
01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
01/14/1999 | WO1999001464A1 Componds and methods for treating and screening viral reactivation |